June 27, 2017 12:22 PM ET


Company Overview of Unipharm, Inc.

Company Overview

Unipharm, Inc. develops, manufactures, and markets pharmaceutical drugs and biologically active food additives. The company produces and sells different types of vitamin-mineral complexes and pharmaceutical drugs. It markets its products under the Artra, Grippex, Melaxen, Vitrum, Glucosamine Sulfate 750, Vitrum, Biovitrum, Multimax, and Unigamma brand names. Unipharm, Inc. is based in Moscow, Russia. Unipharm, Inc. operates as a subsidiary of Unipharm, Inc.

Schabolovka street, 31

Building B

Moscow,  115162



7 495 995 7767


7 095 925 7002

Key Executives for Unipharm, Inc.

Unipharm, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Aknol Europe
Alfarm, Ooo Europe
Angelico Pharmaceuticals Europe
Biomed Im. I.I. Mechnikova, AO Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Unipharm, Inc., please visit www.unipharm.ru. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.